|
The
Institute of Nanotechnology, a global leader in
nanotechnology information services is organising
a public engagement evening ‘Nanomedicine…hype?
Or a real revolution in healthcare?’ on the
28th of November at Royal College of Surgeons of
London. This free event offers an opportunity to
the general public to share their thoughts with
industrial leaders, nanotechnologists and politicians.
Nanotechnology
has found applications in almost every industrial
sector from golf balls to cancer treatment, scratch-free
paints to dirt repellent trousers, and bicycles
to supercomputers. Of all the potential applications
of nanotechnology, nanomedicine - the application
of nanotechnology to healthcare is poised to revolutionise
medical treatments and therapies in areas such
as imaging, faster diagnosis, drug delivery and
tissue regeneration, as well as the development
of new medical products. Analysts predict the
demand for nanomedical products in US alone to
reach $53 billion by 2011.
But
while the potential benefits of nanomedicine are
widely lauded, is there a downside to any of this?
What about the risks of nanotechnology? Are there
adequate controls in place? Regulation? Ethical
issues? Can we afford it? These are all perfectly
valid questions and if nanomedicine is to be successful
they must be clearly and transparently addressed.
The
debate aims to bring together the general public
along with nanotechnologists, researchers, clinicians,
industry, policy makers, regulators, trade associations,
non-governmental organisations, media and other
stakeholders under one roof to discuss and debate
the potential applications of nanomedicine as
well as the social, ethical and environmental
risks.
Expert Panel
 |
- Dr Doug Naysmith MP is a former academic and research immunologist and is now Member of Parliament for Bristol North-West.
|
 |
- Dr Leonard Fass , Director of Academic Relations, GE Healthcare has been closely involved for a number of years in the application of nanotechnology to the fields of medical imaging and biosensors.
|
 |
- Michel Lussier , is a highly successful entrepreneur in the high-technology medical sector and has been responsible for establishing a number of innovative medical technology companies.
|
| |
- Dr. Evdokia Korakianiti , Scientific Administrat or, Pre-Auth orisation Unit for Human Medicines, European Medicines Agency (EMEA).
|
|
 |
- Chair: Geoff Watts , eminent writer and broadcaster on science and medicine. Also currently the presenter of the BBC Radio 4 ‘Leading Edge’ programme.
|
In
the interest of openness and public engagement
this panel discussion and public debate, which
will be held at the Royal College of Surgeons
at 6pm on 28th November 2007,
is open to all and is free. Places are limited
and, therefore, early registration is recommended.
Limited
availability!
Register now >>
|
